119. The Moulds: Aspergillus part 2, invasive and chronic disease

This podcast explores the complexities of diagnosing and treating aspergillosis, a fungal infection with varying presentations based on host immunity. The discussion highlights the challenges in differentiating aspergillosis symptoms from underlying lung disease exacerbations, emphasizing the importance of considering subacute deterioration timelines and utilizing cultures to exclude other infections. Diagnostic approaches, including Aspergillus-specific IgE and IgG testing, are detailed for different patient groups, alongside a caution against relying solely on serum galactomannan in non-neutropenic individuals. Therapeutic options for chronic and acute cases are reviewed, covering azoles, amphotericin B, and echinocandins, with consideration for drug resistance and potential combination therapies. The podcast also touches on upcoming clinical trials and diagnostic guideline updates, underscoring the evolving landscape of aspergillosis management.